SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001387131-18-006055
Filing Date
2018-11-09
Accepted
2018-11-09 16:16:56
Documents
60
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT admp-10q_093018.htm 10-Q 634640
2 DISTRIBUTION AND COMMERCIALIZATION AGREEMENT ex10-1.htm EX-10.1 366037
3 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex31-1.htm EX-31.1 16856
4 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex31-2.htm EX-31.2 16537
5 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER ex32-1.htm EX-32.1 6688
6 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER ex32-2.htm EX-32.2 6717
  Complete submission text file 0001387131-18-006055.txt   3669589

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT admp-20180930.xml EX-101.INS 568060
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT admp-20180930.xsd EX-101.SCH 32876
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT admp-20180930_cal.xml EX-101.CAL 55643
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT admp-20180930_def.xml EX-101.DEF 153419
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT admp-20180930_lab.xml EX-101.LAB 272841
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT admp-20180930_pre.xml EX-101.PRE 223161
Mailing Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 310 SAN DIEGO CA 92130 (858) 997-2400
Adamis Pharmaceuticals Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36242 | Film No.: 181173287
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1